Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Aug 19, 2026 · Filed Aug 25, 2026
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
option exercise
Code M — exercise or conversion of a derivative security
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Insider filing
Traded Sep 14 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider buying
Traded Aug 26 · filed 7 days later
The CEO of Exozymes paid $30 out of pocket for Exozymes shares.
Insider buying
Traded Aug 26 · filed 7 days later
The CEO of Exozymes paid $1.8K out of pocket for Exozymes shares.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.